Dunn FL - Search Results

1

Selective modulation of PPARγ activity can lower plasma glucose without typical thiazolidinedione side-effects in patients with Type 2 diabetes.

Dunn FL, Higgins LS, Fredrickson J, DePaoli AM; INT131-004 study group. Dunn FL, et al. J Diabetes Complications. 2011 May-Jun;25(3):151-8. doi: 10.1016/j.jdiacomp.2010.06.006. Epub 2010 Aug 23. J Diabetes Complications. 2011. PMID: 20739195 Clinical Trial.

2

Can a selective PPARγ modulator improve glycemic control in patients with type 2 diabetes with fewer side effects compared with pioglitazone?

DePaoli AM, Higgins LS, Henry RR, Mantzoros C, Dunn FL; INT131-007 Study Group. DePaoli AM, et al. Among authors: dunn fl. Diabetes Care. 2014 Jul;37(7):1918-23. doi: 10.2337/dc13-2480. Epub 2014 Apr 10. Diabetes Care. 2014. PMID: 24722496 Clinical Trial.

3

Long-term therapy of IDDM with an implantable insulin pump. The Implantable Insulin Pump Trial Study Group.

Dunn FL, Nathan DM, Scavini M, Selam JL, Wingrove TG. Dunn FL, et al. Diabetes Care. 1997 Jan;20(1):59-63. doi: 10.2337/diacare.20.1.59. Diabetes Care. 1997. PMID: 9028695 Clinical Trial.

4

Effect of colesevelam hydrochloride on glycemia and insulin sensitivity in men with the metabolic syndrome.

Vega GL, Dunn FL, Grundy SM. Vega GL, et al. Among authors: dunn fl. Am J Cardiol. 2011 Oct 15;108(8):1129-35. doi: 10.1016/j.amjcard.2011.06.011. Epub 2011 Aug 1. Am J Cardiol. 2011. PMID: 21813109 Clinical Trial.

5

Management of dyslipidemia in people with type 2 diabetes mellitus.

Dunn FL. Dunn FL. Rev Endocr Metab Disord. 2010 Mar;11(1):41-51. doi: 10.1007/s11154-010-9132-6. Rev Endocr Metab Disord. 2010. PMID: 20221703 Review.

6

Oxandrolone enhances hepatic ketogenesis in adult men.

Vega GL, Clarenbach JJ, Dunn F, Grundy SM. Vega GL, et al. J Investig Med. 2008 Oct;56(7):920-4. doi: 10.2310/JIM.0b013e318189153d. J Investig Med. 2008. PMID: 18797410

7

Influence of upper and lower body adipose tissue on insulin sensitivity in South Asian men.

Balakrishnan P, Grundy SM, Islam A, Dunn F, Vega GL. Balakrishnan P, et al. J Investig Med. 2012 Oct;60(7):999-1004. doi: 10.2310/JIM.0b013e3182650a09. J Investig Med. 2012. PMID: 22914598

8

Treatment with artificial beta-cell decreases very-low-density lipoprotein triglyceride synthesis in type I diabetes.

Dunn FL, Carroll PB, Beltz WF. Dunn FL, et al. Diabetes. 1987 May;36(5):661-6. doi: 10.2337/diab.36.5.661. Diabetes. 1987. PMID: 3552799

9

U500 regular insulin use in insulin-resistant type 2 diabetic veteran patients.

Ziesmer AE, Kelly KC, Guerra PA, George KG, Dunn FL. Ziesmer AE, et al. Among authors: dunn fl. Endocr Pract. 2012 Jan-Feb;18(1):34-8. doi: 10.4158/EP11043.OR. Endocr Pract. 2012. PMID: 21742613

10

Plasma lipid and lipoprotein disorders in IDDM.

Dunn FL. Dunn FL. Diabetes. 1992 Oct;41 Suppl 2:102-6. doi: 10.2337/diab.41.2.s102. Diabetes. 1992. PMID: 1526327 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

92 results

Search Page

Filters